Figure (Venlafaxine Fig1)
Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 82009-058
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 82009-058). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Venlafaxine Fig2)
Figure (Venlafaxine Fig3)
This appears to be a table of drug interactions and their effects on certain analytes and PK (pharmacokinetic) parameters. The table includes various drugs such as ethanol, diazepam, indinavir, and caffeine, and their interactions with each other. It also includes information on fold change and 90% confidence interval compared to a reference value.*
Package Label-principal Display Panel (37.5 mg (15 Capsule Bottle))
This is a description of a medication in the form of extended-release capsules. The medication contains Venlafaxine hydrochloride equivalent to 37.5 mg of venlafaxine USP. The capsules come in a package of 1000 capsules, with NDC 82009-056-10. The medication is manufactured by Aurobindo Pharma Limited in Hyderabad, India, and is distributed by Qualint Pharmaceuticals Health LLG in Grand Cayman, Cayman Islands. The usual dosage and further information are available in the accompanying guide to the medication. The capsules should be stored at a temperature between 20°C and 25°C (68°F and 77°F). The package is sealed for protection, with a unique identification numbering system provided for tracking purposes.*
Package Label-principal Display Panel (75 mg (15 Capsule Bottle))
This is a description of a medication containing Venlafaxine hydrochloride, used for extended-release capsules. The capsules are manufactured and provided by Aurobindo Pharma Limited, with each capsule containing 75mg of the active ingredient. The medication is distributed by Quallent Pharmaceuticals Health LLC and is only available through a pharmacist's prescription. The recommended dosage is included in the accompanying USP Extended-Release Capsules information. The medication should be stored at a temperature of 20° to 25°C (68° to 77°F), and the packaging includes a Guide separately provided to each patient. The prescription has a M.L.No.19/HD/AP/95/F/R and a P1431337 identification number. There is a coding area on the packaging with information including an expiry date and lot number, among others.*
Package Label-principal Display Panel (150 mg (15 Capsule Bottle))
This is a description for Venlafaxine Hydrochloride Extended-Release Capsules USP. Each capsule contains 150 mg of Venlafaxine equivalent to Venlafaxine hydrochloride. The manufacturer is Aurobindo Pharma Limited, located in Hyderabad-500 090, India. The product is extended-release and is manufactured for Quallent Pharmaceuticals Health LLC & Grand Cayman, Cayman Islands. The usual dosage and storage instructions are provided, and the pharmacist should dispense medication using the guide provided separately for each patient. The product is sealed for protection and includes a GTIN, Serial Number, Expiry Date Coding Area, and LOT.*
Chemical Structure (Venlafaxine Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
